Austin Health
70
11
14
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.1%
5 terminated/withdrawn out of 70 trials
88.1%
+1.6% vs industry average
14%
10 trials in Phase 3/4
11%
4 of 37 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (70)
Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke
Role: collaborator
Patient-Reported Stent Symptom Outcomes and Migration Rates Following Modified Single-J Ureteric Stent Insertion After Ureteroscopy
Role: lead
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Role: collaborator
Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin
Role: collaborator
The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis
Role: collaborator
Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
Role: collaborator
Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
Role: collaborator
Spinal Cord Injury Neurorecovery Collaboration
Role: collaborator
Use of Water Ingestion in Small Intestine Ultrasound
Role: lead
Food Challenge at Home or in Medical Practice - the FoodCHOMP Study
Role: lead
Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy
Role: collaborator
Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Role: lead
National Robotics-Assisted Radical Prostatectomy Database
Role: collaborator
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Role: collaborator
Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study
Role: lead
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Role: collaborator
A Trial of Radiotherapy and Durvalumab in DLBCL and FL
Role: lead
Adaptive RadioTherapy for OroPharynx Cancer
Role: collaborator
A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
Role: collaborator
Medical Imaging of Cachexia
Role: collaborator